However, in men, inhibition of STMN1 and LRRFIP2 could not overcome dysregulation of the MAPK and Wnt signaling pathways or aberrant cell cycle and apoptosis regulation, thus resulting in cancer. Here, LRRFIP2 is linked to cancer.